Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 05 Jun 2026 for Xeris Biopharma Holdings, Inc.. Read the official filing
Filing timeline
BuySaleJames Aloysius Brady
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
James Aloysius Brady: trading record in brief
James Aloysius Brady is a declared insider at 2 companies; the most frequent names are Xeris Biopharma Holdings, Inc. and Verona Pharma plc. The record holds 5 filings, for trades running from 28 March 2025 to 4 June 2026.
On the market, this insider has only sold: 1 sale, €52k in total. Outside the open market, there are 2 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.
The record was last updated on 5 June 2026 with a share grant in Xeris Biopharma Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Aloysius Brady
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
24,193 shares0Common StockSEC:0001916987-26-000004:0
10,834 shares@ US$5.5414100.0% of flowCommon StockSEC:0001916987-26-000002:0
23,176 sharesOrdinary SharesSEC:0001104659-25-097946:0
24,000 shares0Ordinary SharesSEC:0001104659-25-074391:0
100,000 shares0Common StockSEC:0001867096-25-000058:0
5 of 5 declarations
